Role of Wnt/β-Catenin Pathway in the Arterial Medial Calcification and Its Effect on the OPG/RANKL System

Abstract

In this study, the hypothesis that Wnt/β-catenin pathway is involved in the arterial calcification by regulating the osteoprotegerin (OPG)/receptor activator of NF-κB ligand (RANKL) system was tested. The β-catenin expression was measured in the warfarin-induced calcified arteries and the osteoblast-like cells differentiating from smooth muscle cells (SMCs) by immunohistochemistry and Western blotting. The Wnt/β-catenin pathway was activated or inhibited by lithium chloride (LiCl) or dickkopf 1 (DKK1) in vitro and in vivo. Then the calcification level was determined by von Kossa staining, Ca²⁺ content assay, and alkaline phosphatase (ALP) activity assay. The expression levels of osteocalcin, OPG and RANKL were detected by Western blotting or real-time PCR. The results showed that in calcified arteries and OBL cells, the activation of Wnt/β-catenin pathway significantly enhanced the calcification as evidenced by increased von Kossa stains, Ca²⁺ contents, ALP activities, and osteocalcin expression levels (P<0.05), and it promoted the RANKL expression (P<0.05), but slightly affected the OPG expression. These results indicated that the activation of Wnt/β-catenin pathway worsens the arterial calcification, probably by promoting the RANKL expression.

Keywords

arterial calcification / Wnt/β-catenin pathway / osteoprotegerin / receptor activator of NF-κB ligand

References

[1] RennenbergRJ, SchurgersLJ, KroonAA, et al.. Arterial calcifications. J Cell Mol Med, 2010, 14(9): 2203-2210

[2] ValdivielsoJM. Vascular calcification: types and mechanisms. Nefrologia, 2011, 31(2): 142-147

[3] TsushimaM. Aortic calcification and calcium. Clin Calcium, 2010, 20(11): 1627-1635

[4] HarperE, FordeH, DavenportC, et al.. Vascular calcification in type–2 diabetes and cardiovascular disease: Integrative roles for OPG, RANKL and TRAIL. Vascul Pharmacol, 2016, 7(82): 30-40

[5] NevenE, De SchutterTM, De BroeME, et al.. Cell biological and physicochemical aspects of arterial calcification. Kidney Int, 2011, 79(11): 1166-1177

[6] LeopoldJA. Vascular calcification: Mechanisms of vascular smooth muscle cell calcification. Trends Cardiovasc Med, 2015, 25(4): 267-274

[7] OgawaT, NittaK. Pathogenesis and Management of Vascular Calcification in Patients with End–Stage Renal Disease. Contrib Nephrol, 2018, 196: 71-77

[8] BardeesiASA, GaoJ, ZhangK, et al.. A novel role of cellular interactions in vascular calcification. J Transl Med, 2017, 15(1): 95

[9] NusseR, CleversH. Wnt/ß–Catenin signaling, disease, and emerging therapeutic modalities. Cell, 2017, 169(6): 985-999

[10] KramerI, HalleuxC, KellerH, et al.. Osteocyte Wnt/ beta–catenin signaling is required for normal bone homeostasis. Mol Cell Biol, 2010, 30(12): 3071-3085

[11] KubotaT, MichigamiT, OzonoK. Wnt signaling in bone metabolism. J Bone Miner Metab, 2009, 27(3): 265-271

[12] TrouvinAP, GoëbV. Receptor activator of nuclear factor–?B ligand and osteoprotegerin: maintaining the balance to prevent bone loss. Clin Interv Aging, 2010, 19(5): 345-354

[13] BoyceBF, XingL. The RANKL/RANK/OPG pathway. Curr Osteoporos Rep, 2007, 5(3): 98-104

[14] D’AmelioP, IsaiaG, IsaiaGC. The osteoprotegerin/RANK/RANKL system: a bone key to vascular disease. J Endocrinol Invest, 2009, 32(4): 6-9

[15] ShenC, YuanY, LiF, et al.. Mechanism of genistein regulating the differentiation of vascular smooth muscle cells into osteoblasts via the OPG/RANKL pathway. Oncotarget, 2017, 8(44): 76857-76864

[16] XieH, XiePL, WuXP, et al.. Omentin–1 attenuates arterial calcification and bone loss in osteoprotegerindeficient mice by inhibition of RANKL expression. Cardiovasc Res, 2011, 92(2): 296-306

[17] HelasS, GoettschC, SchoppetM, et al.. Inhibition of receptor activator of NF–kappaB ligand by denosumab attenuates vascular calcium deposition in mice. Am J Pathol, 2009, 175(2): 473-478

[18] Van CampenhoutA, GolledgeJ. Osteoprotegerin, vascular calcification and atherosclerosis. Atherosclerosis, 2009, 204(2): 321-329

[19] SchoppetM, KavurmaMM, HofbauerLC, et al.. Crystallizing nanoparticles derived from vascular smooth muscle cells contain the calcification inhibitor osteoprotegerin. Biochem Biophys Res Commun, 2011, 407(1): 103-107

[20] LiuC, WanJ, YangQ, et al.. Effects of atorvastatin on warfarin–induced aortic medial calcification and systolic blood pressure in rats. J Huazhong Univ Sci Technolog Med Sci, 2008, 28(5): 535-538

[21] Clément–LacroixP, AiM, MorvanF, et al.. Lrp5–independent activation of Wnt signaling by lithium chloride increases bone formation and bone mass in mice. Proc Natl Acad Sci USA, 2005, 102(48): 17406-17411

[22] CastellotJ, FavreauLV, KarnovskyMJ, et al.. Inhibition of vascular smooth muscle cell growth by endothelial cell–derived heparin. Possible role of a platelet endoglycosidase. J Biol Chem, 1982, 257(19): 11256-11260

[23] OlesenP, NguyenK, WogensenL, et al.. Calcification of human vascular smooth muscle cells: associations with osteoprotegerin expression and acceleration by high–dose insulin. Am J Physiol Heart Circ Physiol, 2007, 292(2): 1058-1064

[24] HeoJS, LeeSY, LeeJC. Wnt/ß–catenin signaling enhances osteoblastogenic differentiation from human periodontal ligament fibroblasts. Mol Cells, 2010, 30(5): 449-454

[25] DemerLL, TintutY. Inflammatory, metabolic, and genetic mechanisms of vascular calcification. Arterioscler Thromb Vasc Biol, 2014, 34(4): 715-723

[26] EijkenM, MeijerIM, WestbroekI, et al.. Wnt signaling acts and is regulated in a human osteoblast differentiation dependent manner. J Cell Biochem, 2008, 104(2): 568-579

[27] LiX, LiuP, LiuW, et al.. Dkk2 has a role in terminal osteoblast differentiation and mineralized matrix formation. Nat Genet, 2005, 37(9): 945-952

[28] OsakoMK, NakagamiH, KoibuchiN, et al.. Estrogen inhibits vascular calcification via vascular RANKL system: common mechanism of osteoporosis and vascular calcification. Circ Res, 2010, 107(4): 466-475

[29] PanizoS, CardusA, EncinasM, et al.. RANKL increases vascular smooth muscle cell calcification through a RANK–BMP4–dependent pathway. Circ Res, 2009, 104(9): 1041-1048